Ressources

Protecting Vulnerable Patients From the COVID‑19 Variant Omicron in Hospital

Product: — Evidence Synthesis Network

Hospital Infection Control Transmission Vulnerable Groups Vulnerable Sub-populations

esnetwork.ca Dernière mise à jour: janvier 6, 2022

Ask Ontario’s Science Table: Omicron Edition

Product: — Science Table

Community Prevention & Transmission Epidemiology Transmission Vaccine Vaccines & Immunity

covid19-sciencetable.ca Dernière mise à jour: Décembre 23, 2021

Clinical Practice Guideline Summary: Recommended Drugs and Biologics in Adult Patients with COVID-19

Product: — Science Table

Drug Interventions Infectious Diseases & Clinical Care Practice Guidelines Treatments

covid19-sciencetable.ca Dernière mise à jour: Décembre 22, 2021

Clinical Practice Guideline Summary: Recommended Drugs and Biologics in Adult Patients with COVID-19

Product: — Science Table

Drug Interventions Infectious Diseases & Clinical Care Practice Guidelines Treatments

covid19-sciencetable.ca Dernière mise à jour: novembre 24, 2021

Evidence-Based Recommendations on the Use of Anti-SARS-CoV-2 Monoclonal Antibodies (Casirivimab + Imdevimab, and Sotrovimab) for Adults in Ontario

Product: — Science Table

Infectious Diseases & Clinical Care

covid19-sciencetable.ca Dernière mise à jour: novembre 24, 2021

Clinical Practice Guideline Summary: Recommended Drugs and Biologics in Adult Patients with COVID-19

Product: — Science Table

Infectious Diseases & Clinical Care

covid19-sciencetable.ca Dernière mise à jour: novembre 24, 2021

Design Strategies To Prevent Respiratory Infection In Congregate Care Settings

Product: — Evidence Synthesis Network

Community Prevention & Transmission Infectious Diseases & Clinical Care Practice Guidelines Public Prevention Transmission

esnetwork.ca Dernière mise à jour: novembre 4, 2021

Understanding Long COVID-19

Product: — Evidence Synthesis Network

About Coronavirus Disease Mechanism Epidemiology Infectious Diseases & Clinical Care Long Covid

esnetwork.ca Dernière mise à jour: octobre 29, 2021

Evidence-Based Use of Therapeutics for Ambulatory Patients with COVID-19

Product: — Science Table

Infectious Diseases & Clinical Care

Dernière mise à jour: octobre 18, 2021

COVID-19 : Évaluation des options de désinfection des appareils de protection respiratoire N95 dans le contexte de la pandémie

Product: — Institut national de santé publique du Québec

Decontamination of PPE Face Protection Hospital Infection Control Infection Control Guidelines Infectious Diseases & Clinical Care PPE

www.inspq.qc.ca Dernière mise à jour: septembre 30, 2021

Also available in English